Towards a broader perspective on non-alcoholic fatty liver disease and coronary artery disease relationship: managing metabolic risk beyond genetics - Takeaways - MDSpire

Towards a broader perspective on non-alcoholic fatty liver disease and coronary artery disease relationship: managing metabolic risk beyond genetics

  • By

  • Bernadette Corica

  • Marco Proietti

  • January 17, 2025

  • 0 min

Share

  • 1

    Non-alcoholic fatty liver disease (NAFLD) is linked to increased cardiovascular disease risk, including atherosclerosis and myocardial infarction.

  • 2

    Metabolic dysfunction-associated steatotic liver disease (MASLD) broadens the definition of fatty liver disease, emphasizing metabolic risk factors.

  • 3

    A study found no causal association between genetically predicted NAFLD and coronary artery calcification (CAC), suggesting shared metabolic risk factors.

  • 4

    Advanced stages of NAFLD, particularly with liver fibrosis, are associated with increased pro-inflammatory cytokines and cardiovascular event risk.

  • 5

    Addressing social determinants of health is crucial for improving outcomes in patients with NAFLD and cardiovascular comorbidities.

Original Source(s)

Towards a broader perspective on non-alcoholic fatty liver disease and coronary artery disease relationship: managing metabolic risk beyond genetics

  • by Bernadette Corica, Marco Proietti

  • January 17, 2025

Related Content

FDA Approves Baxdrostat for Resistant Hypertension

Phase 3 findings support the oral therapy in adults with persistent blood pressure elevation despite multidrug treatment.

Grip Strength Plus Waist Size May Flag Risk T2D Risk

Researchers found that patients with higher waist circumference and lower grip strength had the greatest risk for developing type 2 diabetes during long-term follow-up.

Association of organ dysfunction trajectories and major adverse cardiovascular events using clinical obesity in UK Biobank